IPO registrations (S-1, F-1) · Registrants
Axium Pharmaceuticals Inc.
- SEC CIK
- 1715028 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2017-08-21, last 2018-01-11; 1 initial registration, 6 amendments
- Outcome
- Declared effective 2018-01-23
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- NC
- Business address
- 265 EASTCHESTER DR. SUITE 133, #201, Highpoint, NC 27262
- EIN
- 82-1984738
- EDGAR entity type
- other
Offering terms
- Shares offered
- 50,000,000 (all by selling holders)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2017-08-21 | S-1 | S-1 (registration) | Axium Pharmaceuticals Inc. | 0001707451-17-000003 ↗ |
| 2017-10-05 | S-1/A | S-1/A (amendment) | Axium Pharmaceuticals Inc. | 0001707451-17-000006 ↗ |
| 2017-11-13 | S-1/A | S-1/A (amendment) | Axium Pharmaceuticals Inc. | 0001707451-17-000014 ↗ |
| 2017-11-30 | S-1/A | S-1/A (amendment) | Axium Pharmaceuticals Inc. | 0001707451-17-000017 ↗ |
| 2017-12-13 | S-1/A | S-1/A (amendment) | Axium Pharmaceuticals Inc. | 0001707451-17-000020 ↗ |
| 2017-12-28 | S-1/A | S-1/A (amendment) | Axium Pharmaceuticals Inc. | 0001707451-17-000024 ↗ |
| 2018-01-11 | S-1/A | S-1/A (amendment) | Axium Pharmaceuticals Inc. | 0001707451-18-000003 ↗ |
| 2018-01-23 | EFFECT | EFFECT (declared effective) | Axium Pharmaceuticals Inc. | 9999999995-18-000185 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-01-11 | S-1/A | registration statement | $462.18 | 50,000,000 | $23,109,000,000 | 0 | primary document; price table, shares headline, proceeds computed | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Trademark owner | AXIUM PHARMACEUTICALS | NC | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NC first:
- ALDAGEN INC NC
- FENNEC PHARMACEUTICALS INC. NC
- TENGION INC NC
- Chelsea Therapeutics International, Ltd. NC
- AERIE PHARMACEUTICALS INC NC
- PRECISION BIOSCIENCES INC NC
- Immunovant, Inc. NC
- Humacyte, Inc. NC
- PROKIDNEY CORP. NC
- Pelthos Therapeutics Inc. NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health